Richard P Harrigan

Title: The Innovations of Richard P. Harrigan

Introduction

Richard P. Harrigan is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of medical technology, particularly in the area of predicting resistance to therapy in diseases. His innovative approach has the potential to improve patient outcomes by enhancing the accuracy of treatment predictions.

Latest Patents

Harrigan holds a patent for the establishment of biological cut-off values for predicting resistance to therapy. This invention focuses on methods and systems designed to improve the accuracy of predicting a disease's resistance to various therapies. In one embodiment, the invention calculates mean and standard deviation values of fold change in normalized sensitivity, relative to a laboratory wild type standard pathogen or malignant cell. This calculation demonstrates that patient samples exhibit inherently different degrees of variation in susceptibility to each therapy. Additionally, the 2×SD value for each therapy is utilized as the cut-off between sensitive and resistant categories.

Career Highlights

Richard P. Harrigan has built a notable career in the medical technology sector. He is currently associated with Virco Bvba, where he continues to develop innovative solutions that address critical healthcare challenges. His work has garnered attention for its potential to transform therapeutic approaches in clinical settings.

Collaborations

Harrigan has collaborated with talented professionals in his field, including Brendan Larder and Kurt Hertogs. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Richard P. Harrigan's contributions to the field of medical technology exemplify the impact of innovation on healthcare. His patent for predicting resistance to therapy showcases his commitment to improving patient care through scientific advancements.